HSD17B10 and early-onset autosomal dominant Alzheimer disease: Increased concentrations and the degree of oligomerization of Aβ during Alzheimer’s disease may hamper the interaction between 17β-HSD10 and cypD, which may result in the dysregulation of cypD by 17β-HSD10 and apoptosis via increased opening of mitochondrial permeability transition pores.